Buy Now Increasing demand & personalized treatment for solid tumor-based illnesses like cancer, will likely increase the growth of the market. In the dynamic landscape of cancer treatmen… Read More

… Read More

Ever wondered about the people who are leading the fight against cancer, developing groundbreaking treatments, and changing lives? Meet Frank Boriello, the mind behind SUPLEXA cell therapy… Read More

Radiopharmaceuticals are an emerging and promising approach for diagnosing and treating various types of cancer. Radiopharmaceutical therapy (RPT) has demonstrated effectiveness with minimal… Read More

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system… Read More

[Research Report] The antibody drug conjugates market size is projected to reach US$ 29,600.98 million by 2030 from US$ 7,793.43 million in 2022; the market is estimated to record a CAG… Read More

How Therapists can Use the Pupil to Heal Trauma One of the reasons that I left EMDR and started to pursue brainspotting as the primary brain based medicine that I use as a provider was becau… Read More

Antibody drug conjugate (ADC) research involves more and more targets, such as HER-2, Trop-2, Claudin-18.2, B7-H3 and B7-H4, etc. Trop-2 is a transmembrane glycoprotein. Its high expres… Read More

Genprex (NASDAQ: GNPX) is at the forefront of pioneering cancer treatments, and it’s making waves with remarkable advancements in lung cancer therapy. The company will be sharing compe… Read More

On September 29, 2023, Nanobiotix, a renowned clinical biotechnology company, unveiled the final results of a Phase 1 dose expansion study for NBTXR3 in head and neck cancer. This groundbrea… Read More

Peptide Drug Conjugates Market Growth & Trends The global peptide drug conjugates market is expected to reach USD 2.67 billion by 2030, registering CAGR of 18.58% during the fore… Read More

Over the past decade, significant strides have been made in the realm of peptide drug development courtesy of ground-breaking advancements in produc… Read More

Like most individuals, you probably have a mole, or two or three, somewhere on your body. Moles are pretty common. Others gain them during their lifetimes, whereas others are born with them… Read More

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company recently announced that the… Read More

Former VP of Research and Operations steps into new role TAMPA, Fla.–(BUSINESS WIRE)–Nilogen Oncosystems, a privately-held biotechnology company dedicated to increasing efficie… Read More

High-Grade Glioma Clinical Trial DelveInsight’s ‘High-Grade Glioma Pipeline Insight 2023‘ report provides comprehensive global coverage of pipeline High-Grade Glioma t… Read More

Researchers at Brigham and Women’s Hospital in Boston have developed an implant, notably as small as a grain of rice, that can test the effects of drugs on a patient’s brain tumo… Read More

Covalent drugs refer to those drug molecules that form strong bonds with receptors through the formation of covalent bonds. It all began with aspirin in 1899, gained prominence with ibr… Read More

Glutathione (GSH), known as the “King of Antioxidants”, is one of the important antioxidants in mammalian, plant, and microbial cells and an important medical and health product… Read More